Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhalation Anthrax01:25

Inhalation Anthrax

Anthrax is a zoonotic disease caused by Bacillus anthracis, a Gram-positive, spore-forming bacterium. It primarily affects herbivorous animals but can be transmitted to humans through skin contact, ingestion, or inhalation of spores.Cutaneous anthrax, the most common form, typically results from direct contact with bacterial spores through skin abrasions and is generally less severe. Gastrointestinal anthrax results from eating undercooked or contaminated meat. It affects the mouth, throat, or...
Dose-Response Relationship: Overview01:03

Dose-Response Relationship: Overview

Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
Dose Response Curve: Conventional Versus Nonmonotonic01:21

Dose Response Curve: Conventional Versus Nonmonotonic

The correlation between a drug's dosage and its impact on a biological system is a cornerstone of pharmacology and toxicology. Conventional dose–response curves, which include graded and quantal relationships, are key to this understanding. Graded dose–response curves depict the spectrum of a biological reaction to different doses within an individual, indicating that as the drug dosage increases, so does the intensity of the response. On the other hand, quantal dose–response relationships...
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it produces...
Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Consideration of Cardiovascular Morbidities in the Relationship between Ambient Air Pollution Exposure and Individual-Level Adverse COVID-19 Outcomes: A Systematic Review.

Current epidemiology reports·2025
Same author

How to incorporate social vulnerability into epidemic mathematical modelling: recommendations from an international Delphi.

Social science & medicine (1982)·2025
Same author

Deliberating the scientific evidence base for influenza transmission to raw milk consumers.

Risk analysis : an official publication of the Society for Risk Analysis·2025
Same author

The reverse zoonotic potential of SARS-CoV-2.

Heliyon·2024
Same author

Trends in Burdens of Disease by Transmission Source (USA, 2005-2020) and Hazard Identification for Foods: Focus on Milkborne Disease.

Journal of epidemiology and global health·2024
Same author

Comparative Diagnostic Utility of SARS-CoV-2 Rapid Antigen and Molecular Testing in a Community Setting.

The Journal of infectious diseases·2024
Same journal

Re: optimization of interventions in ebola.

Biosecurity and bioterrorism : biodefense strategy, practice, and science·2014
Same journal

Enhancing US-Japan cooperation to combat antimicrobial resistance.

Biosecurity and bioterrorism : biodefense strategy, practice, and science·2014
Same journal

Interfacing a biosurveillance portal and an international network of institutional analysts to detect biological threats.

Biosecurity and bioterrorism : biodefense strategy, practice, and science·2014
Same journal

Regional collaboration among Urban Area Security Initiative regions: results of the Johns Hopkins urban area survey.

Biosecurity and bioterrorism : biodefense strategy, practice, and science·2014
Same journal

Travel bans will increase the damage wrought by ebola.

Biosecurity and bioterrorism : biodefense strategy, practice, and science·2014
Same journal

Global agenda, local health: including concepts of health security in preparedness programs at the jurisdictional level.

Biosecurity and bioterrorism : biodefense strategy, practice, and science·2014
See all related articles

Related Experiment Video

Updated: Jul 4, 2026

Whole-Body Nanoparticle Aerosol Inhalation Exposures
10:11

Whole-Body Nanoparticle Aerosol Inhalation Exposures

Published on: May 7, 2013

Inhalation anthrax: dose response and risk analysis.

Margaret E Coleman1, Brandolyn Thran, Stephen S Morse

  • 1Environmental Science Center, Syracuse Research Corporation, North Syracuse, New York 13212, USA. pcoleman@syrres.com

Biosecurity and Bioterrorism : Biodefense Strategy, Practice, and Science
|June 28, 2008
PubMed
Summary
This summary is machine-generated.

The idea that one Bacillus anthracis spore is lethal is a myth. Scientific evidence shows varying doses determine inhalation anthrax risk, informing better preparedness planning.

More Related Videos

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

Assessment of the Acute Inhalation Toxicity of Airborne Particles by Exposing Cultivated Human Lung Cells at the Air-Liquid Interface
10:10

Assessment of the Acute Inhalation Toxicity of Airborne Particles by Exposing Cultivated Human Lung Cells at the Air-Liquid Interface

Published on: February 23, 2020

Related Experiment Videos

Last Updated: Jul 4, 2026

Whole-Body Nanoparticle Aerosol Inhalation Exposures
10:11

Whole-Body Nanoparticle Aerosol Inhalation Exposures

Published on: May 7, 2013

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

Assessment of the Acute Inhalation Toxicity of Airborne Particles by Exposing Cultivated Human Lung Cells at the Air-Liquid Interface
10:10

Assessment of the Acute Inhalation Toxicity of Airborne Particles by Exposing Cultivated Human Lung Cells at the Air-Liquid Interface

Published on: February 23, 2020

Area of Science:

  • Microbial risk assessment
  • Infectious disease dynamics
  • Biothreats

Background:

  • The belief that a single Bacillus anthracis spore causes fatal inhalation anthrax is widespread but lacks full scientific basis.
  • Current risk assessment for biothreats like anthrax often lacks transparency, hindering accurate preparedness.
  • Misinformation and poor characterization of dose-response relationships complicate biothreat risk analysis.

Purpose of the Study:

  • To clarify the scientific evidence regarding inhalation anthrax dose-response relationships.
  • To challenge the "zero-tolerance" policy for Bacillus anthracis spore detection.
  • To advocate for science-based risk analysis in biothreat preparedness.

Main Methods:

  • Review of existing scientific literature on Bacillus anthracis spore exposure.
  • Analysis of dose-response data from studies in laboratory animals and humans.
  • Examination of mechanisms influencing susceptibility and resistance to anthrax.

Main Results:

  • Evidence indicates that exposures below certain thresholds do not cause inhalation anthrax in humans and animals.
  • Multiple studies document survival and non-fatal outcomes at specific Bacillus anthracis spore doses.
  • The "single spore lethality" notion is not supported by objective scientific data.

Conclusions:

  • Preparedness planning for Bacillus anthracis should move beyond a zero-tolerance policy.
  • Developing non-zero, science-based standards for anthrax spore detection is crucial.
  • Formal risk analysis processes are needed to guide evidence-based biothreat management.